454
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

Impact of COVID-19 on patients with metastatic breast cancer: REthink Access to Care and Treatment survey results

ORCID Icon, , , , , , , , , & show all
Received 10 Mar 2023, Accepted 27 Mar 2024, Published online: 29 Apr 2024

References

  • Azar II AM. Determination that a public health emergency exists. U.S. Department of Health & Human Services, WA, USA (2020). Available at: www.phe.gov/emergency/news/healthactions/phe/Pages/2019-nCoV.aspx
  • World Health Organization. WHO coronavirus (COVID-19) (2022). Available at: https://covid19.who.int/
  • Ueda M, Martins R, Hendrie PC et al. Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal. J. Natl Compr. Canc. Netw. 18, 1–4 (2020). https://jnccn.org/view/journals/jnccn/18/4/article-p366.xml
  • Sheng JY, Santa-Maria CA, Mangini N et al. Management of breast cancer during the COVID-19 pandemic: a stage- and subtype-specific approach. JCO Oncol. Pract. 16(10), 665–674 (2020).
  • Dietz JR, Moran MS, Isakoff SJ et al. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium. Breast Cancer Res. Treat. 181(3), 487–497 (2020).
  • de Azambuja E, Trapani D, Loibl S et al. ESMO management and treatment adapted recommendations in the COVID-19 era: breast cancer. ESMO Open 5(Suppl. 3), e000793 (2020).
  • Kaufman HW, Chen Z, Niles J, Fesko Y. Changes in the number of US patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic. JAMA Netw. Open 3(8), e2017267 (2020).
  • Garg PK, Kaul P, Choudhary D et al. Discordance of COVID-19 guidelines for patients with cancer: a systematic review. J. Surg. Oncol. 122(4), 579–593 (2020).
  • Nakayama J, El-Nashar SA, Waggoner S, Traughber B, Kesterson J. Adjusting to the new reality: evaluation of early practice pattern adaptations to the COVID-19 pandemic. Gynecol. Oncol. 158(2), 256–261 (2020).
  • Lai AG, Pasea L, Banerjee A et al. Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study. BMJ Open 10(11), e043828 (2020).
  • Kurosky S, Liu X, Meche A, Levin R, Sullivan A, McRoy L. Abstract PS11-21: first-line treatment trends in metastatic breast cancer before and at the early stage of the COVID-19 pandemic in the United States. Cancer Res. 81(Suppl. 4), PS11-21-PS11-21 (2021).
  • Rodriguez GM, Ferguson JM, Kurian A, Bondy M, Patel MI. The impact of COVID-19 on patients with cancer: a national study of patient experiences. Am. J. Clin. Oncol. 44(11), 580–587 (2021).
  • Papautsky EL, Hamlish T. Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic. Breast Cancer Res. Treat. 184(1), 249–254 (2020).
  • de Souza JA, Yap BJ, Hlubocky FJ et al. The development of a financial toxicity patient-reported outcome in cancer: the COST measure. Cancer 120(20), 3245–3253 (2014).
  • Shrider EAK, Chen MF, Semega J. Income and poverty in the United States: 2020 (2021). Available at: www.census.gov/library/publications/2021/demo/p60-273.html#:~:text=Median%20household%20income%20was%20%2467%2C521,median%20household%20income%20since%202011
  • Sturz JL, Boughey JC. Lasting impacts of the COVID-19 pandemic on breast cancer diagnosis and treatment in the United States. Surg. Oncol. Clin. N. Am. 32(4), 811–819 (2023).
  • Kaufman HW, Chen Z, Niles JK, Fesko YA. Changes in newly identified cancer among US patients from before COVID-19 through the first full year of the pandemic. JAMA Netw. Open 4(8), e2125681 (2021).
  • Decker KM, Feely A, Bucher O et al. New cancer diagnoses before and during the COVID-19 pandemic. JAMA Netw. Open 6(9), e2332363 (2023).
  • Al-Shamsi HO, Alhazzani W, Alhuraiji A et al. A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an International Collaborative Group. Oncologist 25(6), e936–e945 (2020).
  • Battershill PM. Influenza pandemic planning for cancer patients. Curr. Oncol. 13(4), 119–120 (2006).
  • Mariotto AB, Etzioni R, Hurlbert M, Penberthy L, Mayer M. Estimation of the number of women living with metastatic breast cancer in the United States. Cancer Epidemiol. Biomarkers Prev. 26(6), 809–815 (2017).
  • Gong Y, Liu YR, Ji P, Hu X, Shao ZM. Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study. Sci. Rep. 7, 45411 (2017).
  • Shah AN, Metzger O, Bartlett CH, Liu Y, Huang X, Cristofanilli M. Hormone receptor-positive/human epidermal growth receptor 2-negative metastatic breast cancer in young women: emerging data in the era of molecularly targeted agents. Oncologist 25(6), e900–e908 (2020).
  • SEER. Cancer stat facts: female breast cancer subtypes (2019). Available at: https://seer.cancer.gov/statfacts/html/breast-subtypes.html
  • Ludwigson A, Huynh V, Myers S et al. Patient perceptions of changes in breast cancer care and well-being during COVID-19: a mixed methods study. Ann. Surg. Oncol. 29(3), 1649–1657 (2022).
  • McGrowder DA, Miller FG, Vaz K et al. The utilization and benefits of telehealth services by health care professionals managing breast cancer patients during the COVID-19 pandemic. Healthcare (Basel) 9(10), doi: https://doi.org/10.3390/healthcare9101401 (2021).
  • Dietz JR. Editorial: impact of the covid-19 pandemic on breast cancer treatment and patient experience. Ann. Surg. Oncol. 29(3), 1502–1503 (2022).